Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib monotherapy for refractory cancers with EGFR amplification
KCT0004066Phase 2Recruiting
- Sponsor
- Samsung Medical Center
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in cancer, sponsored by Samsung Medical Center. Started Dec 2014; status: recruiting.
02
Drugs
03
Conditions
cancer
Beyond the preview
Go deeper on KCT0004066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004066.